Higher levels of UA in a sub-group of GDM patients treated by insulin in pregnancy and within the risk group for adverse perinatal outcomes point to possible UA metabolism disturbance associated with a more severe glucose homeostasis problem. This evidence concerns the gene INS and gestational diabetes.